The revised tool for assessing risk of bias in randomized trials (RoB 2.0) was published in late 2019, building on the established Cochrane risk-of-bias tool first released through the Cochrane Handbook in 2008.
This webinar introduced the revised tool and discuss its development and application, highlighting the major changes from the original tool. A guided walk-through of some of the key domains was presented.
Luke is an NIHR Doctoral Research Fellow at the University of Bristol Medical School, where he is attempting to integrate multiple sources of epidemiological evidence to improve our understanding of dementia risk factors. He is an experienced evidence synthesis methodologist, particularly with respect to risk-of-bias assessment and systematic review software. He is the author of robvis, a web application that allows users to quickly produce risk-of-bias summary figures, and is currently coordinating the development of a new online platform that will help researchers manage and perform risk-of-bias assessments.
Theresa has extensive experience of carrying out and managing systematic reviews in a range of topics including prostate cancer, mental health, domestic violence and abuse, and reviews of public health interventions, such as changes to the built environment and preventing obesity in children. Her systematic reviews have covered a range of methods; including reviews of interventions with both RCTs and non-randomised studies, systematic reviews of the effects of exposure and systematic reviews of qualitative research. Theresa is currently based in the Bristol Medical School within the National Institute of Health Research (NIHR) Applied Research Collaboration West (ARC West) in the Bristol Appraisal and Review of Research (BARR Group) and works for the Cochrane Collaboration as Systematic Review Methodological Editor in the Methods Support Unit.